Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dual-specificity phosphatases as targets for antineoplastic agents.

Michael A Lyon1, Alexander P Ducruet, Peter Wipf

  • 1Department of Chemistry, Chevron Science Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.

Nature Reviews. Drug Discovery
|December 4, 2002
PubMed
Summary

Dual-specificity phosphatases regulate cell signaling. This review summarizes key developments in their biology and medicinal chemistry for targeted drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting PTP4A3 with KVX-053 mitigates alcohol-amplified SARS-CoV-2 spike protein-induced acute lung injury.

Frontiers in pharmacology·2026
Same author

The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice.

Respiratory research·2025
Same author

KVX-053, a protein tyrosine phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 spike protein subunit 1-induced acute lung injury in mice.

The Journal of pharmacology and experimental therapeutics·2025
Same author

Deletion of PTP4A3 phosphatase in high-grade serous ovarian cancer cells decreases tumorigenicity and produces marked changes in intracellular signaling pathways and cytokine release.

The Journal of pharmacology and experimental therapeutics·2025
Same author

KVX-053, a Protein Tyrosine Phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 Spike protein subunit 1 - induced acute lung injury in mice.

The Journal of pharmacology and experimental therapeutics·2024
Same author

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.

Nature medicine·2024

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Dual-specificity protein phosphatases (DSPs) are critical regulators of cellular signaling pathways.
  • They dephosphorylate both tyrosine and serine/threonine residues, impacting cell stress, proliferation, and death.
  • DSPs are increasingly important targets in pharmaceutical drug discovery.

Purpose of the Study:

  • To provide a comprehensive overview of recent advancements in DSP biology.
  • To summarize key developments in the medicinal chemistry of DSPs.
  • To stimulate further research into small-molecule inhibitors for therapeutic applications.

Main Methods:

  • Literature review and synthesis of existing research on dual-specificity phosphatases.
  • Analysis of biological roles and signaling pathway involvement.

Related Experiment Videos

  • Evaluation of medicinal chemistry efforts and small-molecule inhibitor development.

    • Main Results:

    • Detailed summary of the diverse biological functions of DSPs.
    • Overview of current strategies and challenges in developing DSP inhibitors.
    • Identification of key areas for future research and drug development.

    Conclusions:

    • Dual-specificity phosphatases play a central role in cellular regulation and are promising therapeutic targets.
    • A comprehensive understanding of their biology and chemistry is crucial for developing novel drugs.
    • This review aims to accelerate the development of targeted therapies based on DSP modulation.